Atlas Trials

Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer Screening

Clinical trial NCT04322045 · UNKNOWN

Trial details

NCT number
NCT04322045
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2020-04-01
Primary completion
2022-12-01
Enrollment
10000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.